Background: While much is known about correlates of C-reactive protein (CRP), little is
INTRODUCTION
A vast literature over the past decade links low-grade, systemic inflammation with many chronic diseases, such as type 2 diabetes (1), cardiovascular disease (CVD) (2) , and many cancers (3) , although the mechanisms for these associations are not entirely clear. Against this background, many circulating biomarkers of inflammation, e.g., cytokines, acute-phase proteins, chemokines and other soluble immune factors, are commonly evaluated to determine disease risk. Given that these biomarkers are increasingly used in epidemiologic and intervention studies, it is important to establish whether certain factors are consistently associated with inflammation biomarker concentrations, and how these determinants differ based on the biomarker under study. While factors affecting circulating concentrations of some cytokines have been well-characterized, e.g., increasing age and higher body mass index are associated with greater blood concentrations of C-reactive protein (CRP) (4) (5) (6) , less is known about correlates of other biomarkers of inflammation. Additionally, much of the prior work has been carried out among individuals with chronic conditions. In the present analysis, we examined the associations of 38 exposures, including demographic factors, anthropometric measures, history of chronic disease, medication use, dietary factors and supplement use, with a panel of 8 inflammation biomarkers [CRP, prostaglandin E 2 -metabolite (PGE-M), interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor-alpha (TNF-α), and the soluble TNF receptors (sTNFR) I
and II], to identify similarities and differences in the associations with these biomarkers.
MATERIALS AND METHODS

Study population
The VITAL biomarker study includes 220 individuals drawn from the parent VITAL cohort, a prospective study of 77,719 western Washington residents aged 50-76 years, focused on supplement use in relation to cancer incidence (7) . VITAL study participants who completed the VITAL questionnaire between October 2000 and February 2001, lived in the Seattle metropolitan area, and did not have insulin-dependent diabetes were randomly selected for participation in the VITAL biomarker sub-study. Of the 290 individuals contacted, 220 (76%) agreed to participate and completed the study protocol. The biomarker study consisted of a second mailed validity questionnaire and an in-home visit about 3-4 months after baseline, at which time an interview was conducted and fasting blood and spot urine were collected. All participants provided written informed consent and study procedures were approved by the Similarly for smoking, a pack-years variable was derived for each questionnaire, then averaged and categorized as: never-smoker, pack-years below the median, or pack-years above the median. Alcohol consumption was assessed by a food frequency questionnaire (FFQ) and categorized as tertiles of intake. Recreational physical activity was determined through a series of questions on minutes/day and days/week of 14 types of activities, plus intensity for walking.
This information was used to categorize individuals as engaging in any moderate/vigorous activity in the month prior (no/yes). History of cancer excluded history of non-melanoma skin cancers. History of CVD was defined by a self-reported history of any of myocardial infarction, angina, angioplasty, coronary bypass surgery, or stroke. Use of low-dose aspirin, regular aspirin, and NSAIDs was defined as current days per week of use, categorized as 0, 1-3 days/week, or 4+ days/week. Use of HRT and cholesterol lowering drugs were defined as current use (yes/no).
We also examined dietary factors [total energy, fiber, saturated fat, alpha-tocopherol, and gamma-tocopherol intake, vitamin C, vitamin D, beta carotene, and long-chain omega-3 polyunsaturated fatty acids (PUFA)], supplement use (fiber, vitamin C, vitamin D, vitamin E, beta carotene, fish oil, and multivitamins), plus total dietary + supplemental intake (fiber, alpha-tocopherol, vitamin C, vitamin D, beta carotene, and long-chain omega-3 PUFA).
Dietary factors were assessed by an FFQ embedded within the main questionnaire. This FFQ was adapted from that used in the Women's Health Initiative and captures intake and serving size of 120 foods and beverages (7) . The University of Minnesota's Nutrition Coding Center Database was used to convert FFQ data into nutrient intake. Participants were excluded from nutrient calculations if they did not complete all pages of the FFQ or if they reported biologically implausible energy intake (men reporting <800 kcal/day or >5000 kcal/day; women reporting <600 kcal/day or >4000 kcal/day) (8) . Dietary variables from each of the two FFQ completed were averaged in order to reduce measurement error.
Use of vitamins C, D, E, and beta-carotene, was ascertained at a supplement inventory performed at the time of the biomarker study home visit. For each supplement currently taken, interviewers ascertained frequency of use and number of pills taken, and vitamin or mineral dose per pill from each supplement bottle label. This information was used to calculate the average amount of each supplement taken/day as follows: [(days/week)/(7 days/week)] x [dose per day], summed over the individual supplements and multivitamins containing the nutrient of interest. These supplements were categorized as no use, low use, and high use, with the threshold between low use and high use set so as to best separate intake from multivitamins and individual supplements using dosing information on popular multivitamins at the time of questionnaire. The following thresholds were used to separate high use of supplements: vitamin C (>560 mg), vitamin D (>10 mcg), vitamin E (>430 mg), and beta-carotene (>600 µg).
Fish oil, fiber and multivitamin supplement use were categorized as current use/no use.
Appropriate weighting was used to yield dietary + supplemental intake of alpha-tocopherol (mg) and beta-carotene (µg), while total diet + supplemental EPA+DHA was calculated using an estimate of supplemental dose (9) . The VITAL biomarker study was used as the data source for all exposures unless otherwise noted. If information on a given variable was missing in the VITAL validity questionnaire, information was pulled from the VITAL baseline questionnaire.
Outcomes and Exclusions
Given the skewed distribution of the biomarker data, all outcomes were log-transformed using the natural logarithm. Pearson correlation coefficients were used to evaluate the correlation between biomarkers. Multivariable-adjusted linear regression was used to evaluate the association between categories of each exposure and each biomarker; the exponentiated betas for each exposure are interpreted as the ratio of the biomarker for each exposure category compared to the lowest exposure category. The Wald test was used to test for a statistical difference in biomarker values for binary exposures. For tests for trend in the biomarker values across values of other exposures, the exposure was modeled as continuous for underlying continuous variables and as grouped linear for ordered categorical variables. The exception to this is that alcohol was tested for its association with each biomarker using a global p for differences among the tertiles of alcohol intake, as alcohol effects are often not linear trends.
All models were adjusted for age (continuous), sex, and BMI (continuous), and all models with diet variables were additionally adjusted for energy intake. To determine the percent of variance exposures explained, R 2 values were calculated for each biomarker including all significant factors for that particular biomarker in a single model. Stata (v 12; StataCorp, College Station, TX) was used for all analyses. Since the goal of this study was to examine consistencies between exposures and the 8 biomarkers, we discuss associations that were nominally significant (p<0.05), rather than use a more stringent p value that is adjusted for multiple testing to provide readers with a framework of biomarker consistency. 
RESULTS
DISCUSSION
To our knowledge, no other study has simultaneously evaluated the associations of a large number of exposures across a panel of circulating inflammation biomarkers. In this study, the most consistent associations with systemic inflammation were age, BMI, and intakes of saturated fat and EPA and DHA omega 3 PUFAs. More factors were associated with CRP concentrations than any other marker we evaluated. Surprisingly, increasing BMI, a strong determinant of CRP concentrations in this study and others (5, 12) , was only significantly associated with higher concentrations of sTNFRI and II, but not any of the other proinflammatory cytokines commonly thought to be elevated in obesity. Also unexpected, was a lack of an association between higher intakes of fiber with any of the biomarkers other than CRP.
Demographic
It is well established that CRP, the most widely studied of the biomarkers of inflammation, increases with age (4, 13-15). We found similar increases with age for the other biomarkers, except IL-1beta, consistent with other studies (16, 17) . Women have also been shown to have consistently higher concentrations of CRP (11, 13, 14, 18, 19) ; however, among the other markers, only IL-6 was higher among women, while PGE-M and sTNFRI appeared to be somewhat higher among men. The data on sex differences in these biomarkers of inflammation, other than CRP, are either mixed (20-23) or lacking.
Although age-associated increases in many inflammation biomarkers correlate with chronic disease (15), the mechanisms for sex differences remain inconclusive. Hormone use is thought to be a contributor as women using estrogen have higher CRP concentrations than those who do not (24-26). Indeed, in the present study, women who reported current use of HRT had 74%
higher CRP concentrations. Greater adiposity in women may play a role, though sex differences in CRP remain, in our study and in others, even after adjustment for HRT and BMI (24, 25, 27, 28). Rossi, et al (19) found that sex differences in the relationship between CRP and adiposity were mediated by leptin. Variants in the leptin receptor have previously been shown to correlate with circulating CRP concentrations (29). Thus, it is possible that leptin is partly responsible for sex-mediated differences in CRP, but teasing apart the contributions of leptin versus adiposity will be difficult, and there are likely other, as yet unidentified factors.
Lifestyle/Anthropometric
As others have noted, concentrations of many biomarkers of inflammation increase among Regular physical activity is fairly consistently associated with lower concentrations of many markers of systemic inflammation; (15, (39) (40) (41) (42) however, the only markers that were significantly decreased with increased physical activity in our panel were CRP and sTNFRII. One of the mechanisms by which physical activity may reduce inflammation, other than through reducing body mass which was adjusted for in our analysis (43) , is protection from CVD and diabetes, which are associated with increased inflammation. There is also some evidence that exercise elevates antioxidant defenses (43, 44) .
CRP concentrations were higher among individuals who reported smoking 18 or more packyears compared to never-smokers, with a similar but borderline significant association with PGE-M. The association between smoking and increased concentrations of inflammatory markers has long been recognized (4, (45) (46) (47) . In addition to activation of NF-κB,-a transcription factor and central mediator of the inflammatory response, exposure to cigarette smoke increases production of reactive oxygen species (46) , and cyclooxygenase (COX), a rate-limiting enzyme in the production of PGE 2 (48, 49) .
Alcohol consumption was inversely associated with one biomarker, sTNFRII, thought to act as a buffer by removing TNF-α from circulation, but also itself is involved in apoptotic and proinflammatory signaling in response to TNF-α binding (50) . Concentrations typically rise in parallel to increasing TNF-α concentrations (50) . As plasma TNF-α concentrations are generally much lower, and measurement less accurate owing to interactions with their cognate receptors, sTNFRI and II are often used as surrogate measures of TNF-α concentrations (50) .
Data evaluating the association of alcohol intake and concentrations of these soluble receptors in healthy adults are sparse. Results of a population-based inflammation index based on literature-derived dietary intake and a panel of six inflammation markers found that alcohol intake at ~14 g/day was associated with decreased systemic inflammation (51), although sTNFRI and II were not included in the panel. Polyphenols such as resveratrol in red wine (52) and hops in beer (53) may contribute to an anti-inflammatory effect through inhibition of the transcription factor NF-κB (54) .
Medication use
While use of aspirin and NSAIDs might be expected to reduce biomarkers of inflammation, with significantly lower concentrations of PGE-M. PGE-M is a stable metabolite of PGE 2 and is used as a surrogate measure of systemic PGE 2 concentrations (60). By irreversibly acetylating COX-1 and modifying the activity of COX-2, aspirin inhibits the enzymes involved in the conversion of arachidonic acid into proinflammatory prostaglandins (61) . There is also evidence that aspirin is involved in inflammation resolution programs through enhanced conversion of resolvins, protectins and other proresolution mediators derived from long chain omega 3 fatty acids (62) . These mediators serve to halt the production and trafficking of proinflammatory factors (63) . While the effects of aspirin on PGE 2 have been well-documented (64), few studies have directly evaluated the association of aspirin use and PGE-M concentrations in urine, with inconsistent results (65, 66) .
Medical history
Contrary to the majority of the literature showing higher CRP concentrations with CVD (67), in our analysis, a history of CVD was associated with lower CRP. It is important to note that our evaluation was based on previous disease history. In response to disease diagnosis, many individuals make diet and lifestyle changes, and begin pharmaceutical interventions. In our data, the association did not attenuate with adjustment for use of statins or aspirin. Many studies show a positive association between higher circulating inflammation concentrations and cancer incidence (3, 68, 69) . The only biomarkers in our study that were associated with a history of cancer were the soluble TNF receptors, and the concentrations were only modestly higher in those with a history of cancer compared to those without. As with CVD, it is likely that cancer survivors make lifestyle changes after diagnosis, and higher systemic inflammation will only be captured close to the time of on-going cancer pathology.
Dietary intake
A growing body of evidence suggests that diet and dietary patterns can influence concentrations of biomarkers of systemic inflammation (51, 70) . Of the dietary factors evaluated, a consistent pattern was observed between increasing intakes of saturated fat and increasing concentrations of CRP, sTNFRII, TNF-α, and IL-1β, with concentrations more than two and a half times greater in the highest quartile of intake (vs. the lowest) for CRP and IL-1β.
Additionally, IL-6 concentrations were twice as high for those in the highest quartile of saturated fat, but this result was not statistically significant. Saturated fat has been hypothesized to contribute to inflammation through activation of toll-like receptor (TLR) pathways involved in innate immunity, particularly TLR-4 (71) . TLRs, in turn, stimulate NF-kB, a transcription factor that regulates a battery of immune factors, including cytokines and chemokines (72) .
A systematic review recently assessed the association of saturated fat and circulating concentrations of inflammation and adipokines. Data were available for several markers of inflammation, including intercellular and vascular adhesion molecules (ICAM-1 and VCAM-1, respectively), CRP, IL-6, TNF-α, and adiponectin (73) . Higher intakes of saturated fat were positively associated with CRP, IL-6, and ICAM-1 (73) . In another study, erythrocyte fatty acid composition in 55 healthy adults was compared to serum CRP and IL-6 concentrations (74). In 
Several limitations of this analysis should be noted. Most exposures were based on self-report and are subject to measurement error. However, we attempted to reduce this error in the dietary exposures by using the average of two FFQ, and to reduce the error in relation to supplement use by recording information taken directly from product bottles in the participants' homes. The biomarkers also are subject to error. The interleukins and TNF-α were multiplexed on a 4-plex assay, which may have had less precision than measuring each marker independently. As evidenced in the correlation matrix (Table 2 ), biomarkers included in the 4-plex assay (TNF-α, IL-1β, IL-6 and IL-8) were correlated, while no specific patterns emerged for the remaining biomarkers. Further, the biomarkers which were multiplexed had higher CVs, although all CVs were <15%. As samples were stored for several years, some degradation may have taken place. Whereas CRP has been shown to be a stable marker over time and is not sensitive to diurnal fluctuations, less information is known about the other markers. These effects would likely have attenuated the associations between the exposures and biomarkers.
We also note that some of the significant trends for the dietary exposures were not linear. For example, the second quintile of vitamin C intake was associated with higher CRP while the third and fourth were associated with lower CRP concentrations. This may suggest that protective effects are only observed with higher intakes. For saturated fat, we observed the converse; the second quintile was associated with lower concentrations of some inflammation biomarkers, but intakes above that level were associated with increased inflammation biomarker concentrations. This suggests that any confounding effect of these factors may not be best modeled as linear. Regarding the data analyses, our sample size was small, leading in many instances to wide confidence intervals. Furthermore, adjustment for multiple comparisons was not made, as our goal was to look for similarities in associations across the biomarkers and to inform researchers on what factors should be considered as potential confounders to be adjusted for in future studies. However, some of our findings, particularly those in the p-value range of 0.01-0.05 could be due to chance. While we did adjust for a priori selected confounders in our analyses, e.g., age, sex, BMI and energy intake, residual confounding by other factors may bias our results. For example, saturated fat or n-3 PUFA may be markers of unhealthy or healthy lifestyle or dietary habits, respectively, and these observed associations should be interpreted with caution. While a higher percentage of variance was explained with all of the significant factors for CRP (R 2 =0.44) and sTNFRII (R 2 =0.30), the variance explained for the other markers was modest (R 2 <0.10).
Finally, as our study participants were primarily Caucasian, our results may not be generalizable 
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All values log-transformed prior to correlation analysis. ABBREVIATIONS: CRP (C-reactive protein); IL-1β (interleukin 1-beta); IL-6 (interleukin-6); IL-8 (interleukin-8); PGE-M (prostaglandin E 2 metabolite); TNFα (tumor necrosis factor alpha); sTNFRI (soluble tumor necrosis factor receptor 1); sTNFRII (soluble tumor necrosis factor 2) Ratio=e β in a model in which the dependent variable is ln(biomarker). All models were adjusted for age (continuous), sex, and BMI (continuous), except the models for age as categories include age (categorical), sex, and BMI (continuous) and the models for BMI as categories include age (continuous), sex, and BMI (categorical). All dietary and dietary+supplement exposures were additionally adjusted for energy intake c Includes all individually significant factors (p<0.05) for the biomarker in a single model Ratio=e β in a model in which the dependent variable is ln(biomarker). All models were adjusted for age (continuous), sex, and BMI (continuous), except the models for age as categories include age (categorical), sex, and BMI (continuous) and the models for BMI as categories include age (continuous), sex, and BMI (categorical). All dietary and dietary+supplement exposures were additionally adjusted for energy intake c Includes all individually significant factors (p<0.05) for the biomarker in a single model
